Extrarenal benefits of SGLT2 inhibitors in the treatment of cardiomyopathy
{{output}}
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have emerged as pivotal medications for heart failure, demonstrating remarkable cardiovascular benefits extending beyond their glucose-lowering effects. The unexpected cardiovascular advantages have intrigued a... ...
